Display Settings:

Format

Send to:

Choose Destination
    Bioorg Med Chem Lett. 2010 Aug 15;20(16):4901-5. Epub 2010 Jun 25.

    An orally bioavailable positive allosteric modulator of the mGlu4 receptor with efficacy in an animal model of motor dysfunction.

    Source

    Evotec (UK) Ltd, 114 Milton Park, Abingdon, OX14 4SD, UK. stephen.east@evotec.com

    Abstract

    A high-throughput screening campaign identified 4-((E)-styryl)-pyrimidin-2-ylamine (11) as a positive allosteric modulator of the metabotropic glutamate (mGlu) receptor subtype 4. An evaluation of the structure-activity relationships (SAR) of 11 is described and the efficacy of this compound in a haloperidol-induced catalepsy rat model following oral administration is presented.

    2010 Elsevier Ltd. All rights reserved.

    PMID:
    20638279
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Elsevier Science

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk